BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3431740)

  • 21. [Policy for patients with a class IIIA cervical smear, mild dysplasia].
    Kwikkel HJ; Helmerhorst TJ; Quaak MJ; Stolk JG
    Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1677-80. PubMed ID: 4047226
    [No Abstract]   [Full Text] [Related]  

  • 22. Experience with the Oxford tumour marker in uterine cervical lesions.
    Beltrami CA; Di Loreto C; De Nictolis M; Stramazzotti D
    Appl Pathol; 1984; 2(1):39-42. PubMed ID: 6395880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Statistical findings on cytological diagnosis of cervical carcinoma].
    Pavesi M; Pastormerlo M; Salzani P
    Minerva Ginecol; 1986 Jun; 38(6):473-4. PubMed ID: 3737005
    [No Abstract]   [Full Text] [Related]  

  • 24. Carcinoma in situ of the cervix and its malignant potential. A lesson from New Zealand.
    Chang AR
    Cytopathology; 1990; 1(6):321-8. PubMed ID: 2101679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical intraepithelial neoplasia (dysplasia and carcinoma in situ) and early invasive cervical carcinoma.
    Nelson JH; Averette HE; Richart RM
    CA Cancer J Clin; 1989; 39(3):157-78. PubMed ID: 2496898
    [No Abstract]   [Full Text] [Related]  

  • 26. Accuracy of the diagnosis in suspected intraepithelial neoplasia of the cervix.
    Myllynen L; Karjalainen O
    Ann Chir Gynaecol; 1984; 73(1):45-9. PubMed ID: 6732157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytologic-histologic correlation in 900 conizations].
    Hohlweg-Majert P; Hettenbach A; Kübler HC
    Fortschr Med; 1985 May; 103(18):473-6. PubMed ID: 4007744
    [No Abstract]   [Full Text] [Related]  

  • 28. [Histo-cytologic study on the development of moderate cervical dysplasia (cervical intraepithelial neoplasm 2) followed in 267 cases].
    Eleuteri Serpieri D; Buzzi M; Palazzetti PL; Alessandrini A
    Minerva Ginecol; 1986 Mar; 38(3):139-42. PubMed ID: 3703365
    [No Abstract]   [Full Text] [Related]  

  • 29. RO-TAGE biopsy. An improved method of endocervical evaluation.
    Mann WJ; Chumas J; Rochelson B; Funt M; Westermann C
    J Reprod Med; 1985 May; 30(5):376-8. PubMed ID: 4009558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the agreement between cytological and histological examinations in the diagnosis of cervical cancer].
    Kujawska E; Waszyński E
    Wiad Lek; 1981 Aug; 34(15):1263-6. PubMed ID: 7331327
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of patients with positive margins after cervical conization.
    Lapaquette TK; Dinh TV; Hannigan EV; Doherty MG; Yandell RB; Buchanan VS
    Obstet Gynecol; 1993 Sep; 82(3):440-3. PubMed ID: 8355949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis of cervical dysplasias].
    Pérez Dettoma J; Santamaría M; Jurado M; Cabezón C; Domínquez J; de la Fuente F; López García G
    Rev Med Univ Navarra; 1980 Dec; 24(4):26-9. PubMed ID: 7336009
    [No Abstract]   [Full Text] [Related]  

  • 33. [Histological diagnosis of precancerous and early stages in cancer of the cervix uteri].
    Bajardi F
    Osterr Z Erforsch Bekampf Krebskr; 1970; 25(2):101-18. PubMed ID: 5317567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytology and colposcopy in the diagnosis and management of outpatients with cervical intraepithelial neoplasia.
    Allahverdian V; Valaitis J; Kalis O; Pearlman S
    J Reprod Med; 1980 Jan; 24(1):1-4. PubMed ID: 7359496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CIN or not CIN.
    Giacomini G; Simi U
    Acta Cytol; 1983; 27(5):543-7. PubMed ID: 6578653
    [No Abstract]   [Full Text] [Related]  

  • 36. [Histology of premalignant changes in the cervix uteri].
    Torhorst J
    Gynakologe; 1981 Dec; 14(4):199-203. PubMed ID: 7033079
    [No Abstract]   [Full Text] [Related]  

  • 37. Morphometric analysis of dysplasia in cervical cone biopsy specimens in cases with false-negative cytology.
    Hartman B; Kaplan B; Boone D
    Obstet Gynecol; 1986 Dec; 68(6):832-6. PubMed ID: 3785796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [I. Uterine cervical neoplasms 2. Strategy for treatment of adenocarcinoma in situ of uterine cervix and the role of chemotherapy ].
    Hongo A
    Gan To Kagaku Ryoho; 2012 Feb; 39(2):184-9. PubMed ID: 22545284
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cytomorphologic signs of severe dysplasia and cancer of the uterine cervix].
    Slavnova EN
    Lab Delo; 1989; (5):32-4. PubMed ID: 2473256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The invasive potential of carcinoma in situ of the cervix.
    McIndoe WA; McLean MR; Jones RW; Mullins PR
    Obstet Gynecol; 1984 Oct; 64(4):451-8. PubMed ID: 6483293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.